
Disrupting Drug Development – Nasha Fitter’s Mission to Transform Rare Disease Research
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode of The Clinical Research Coach, host Leanne Woehlke sits down with trailblazer Nasha Fitter—tech entrepreneur, rare disease advocate, and co-founder of both the FOXG1 Research Foundation and Citizen Health.
After Nasha’s daughter was diagnosed with FOXG1 syndrome, an ultra-rare neurological disorder, her world shifted. Instead of accepting the limitations of the current research landscape, she took action- building a foundation, galvanizing the scientific community, and redefining what’s possible for families facing rare disease.
What began as a grassroots foundation now drives innovative drug development, redefines data collection, and challenges the status quo in drug development.
In this conversation, Nasha shares:
- How a small, determined parent community raised $10M and launched a gene therapy program
- Why traditional research models fail rare disease patients—and how to fix them
- The power of patient-owned data and how platforms like Citizen Health are transforming access and insights
- How to build empathy for families navigating special needs
- What pharma gets wrong (and right) in working with advocacy groups
- Her vision for a precision medicine future—starting with ultra-rare
This is a story about courage, creativity, and a more inclusive, patient-driven future of medicine. Nasha’s bold vision and action oriented approach will leave you inspired and hopeful.
To Find Out More:
Nasha Fitter
https://www.linkedin.com/in/nashafitter/
FOXG1 Research Foundation:
https://www.foxg1research.org/
Citizen Health:
https://www.citizen.health/